S.2621

Establishes "Equitable Drug Pricing and Patient Access Act."

Introduced·1/13/26
Introduced Text

Establishes the "Equitable Drug Pricing and Patient Access Act" to ensure fair reimbursement rates for Medicaid prescription drugs.

The "Equitable Drug Pricing and Patient Access Act" sets a minimum reimbursement rate for prescription drug services in Medicaid, ensuring it is no less than the national average drug acquisition cost plus a Medicaid fee-for-service. The act mandates that Medicaid managed care contracts include pharmacy choice as a required benefit, allowing enrollees to choose any qualified pharmacy. It also requires the State Auditor to audit pharmacy pricing practices within the Medicaid program to determine potential savings.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health, Human Services and Senior Citizens Committee
Next
Committee decision

Sponsors

DDDD
4
1
R
Democratic CaucusRepublican Caucus

History

Jan 13

Senate

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee